Correction to: novel biphenyl diester derivative AB-38b inhibits NLRP3 inflammasome through Nrf2 activation in diabetic nephropathy

Lei Du; Jin Wang; Yibing Chen; Xizhi Li; Lei Wang; Yuan Li; Xiaoping Jin; Xiaoke Gu; Meng Hao; Xia Zhu; Xiaoxing Yin; Qian Lu

doi:10.1007/s10565-020-09512-w

Correction to: novel biphenyl diester derivative AB-38b inhibits NLRP3 inflammasome through Nrf2 activation in diabetic nephropathy

Cell Biol Toxicol. 2020 Aug;36(4):389-390. doi: 10.1007/s10565-020-09512-w.

Authors

Lei Du¹, Jin Wang¹, Yibing Chen¹, Xizhi Li¹, Lei Wang¹, Yuan Li¹, Xiaoping Jin¹, Xiaoke Gu¹, Meng Hao¹, Xia Zhu¹, Xiaoxing Yin², Qian Lu³

Affiliations

¹ Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, 209 Tongshan Road, Xuzhou, 221004, Jiangsu, China.
² Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, 209 Tongshan Road, Xuzhou, 221004, Jiangsu, China. yinxx@xzhmu.edu.cn.
³ Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, 209 Tongshan Road, Xuzhou, 221004, Jiangsu, China. prairy@126.com.

PMID: 31970602
DOI: 10.1007/s10565-020-09512-w

Abstract

Unfortunately, there are some tiny errors in the data for Fig. 1a-c and Fig. 2a-e in the published online paper. Please see the correct relative data in Tables 3 and 4 given in the next page. These errors does not interfere the results and conclusions of authors study.

Publication types

Published Erratum